ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666496 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666496; 2) Community: the network communities that were significantly associated with the response to NSC 666496; 3) Molecule: the relationships between components within communities and NSC 666496; 4) MDR: the compounds that were significantly associated with the NSC 666496.

NSC Compound Enrichment Correlation
NSC 648365 Insulin-Methotrexate conjugate 0.0306776553926119 0.067679643
NSC 650931 2'-BROMO-4'-EPI-DAUNDRUBICIN 0.0306776553926119 -0.030895266
NSC 661229 Null 0.0306776553926119 -0.11663586
NSC 661748 [6,6'-Bibenzo[6,7]cyclohepta[1,2,3-cd]benzofuran]-4,4',8,8', 10,10'-hexol, 1,1',6,6',7,7',11b,11'b-octahydro-1,1',7,7'- tetrakis(4-hydroxyphenyl)-, [1.alpha.,6.beta.(1'R*,6'S*,7'R*),7.alpha]- 0.0306776553926119 0.27419038
NSC 665484 Null 0.0306776553926119 0.34377528
NSC 666571 7.alpha.-Methyl-3,11.beta.,17.beta.-trihydroxy estra-1,3,5(10)triene 11-nitrate ester 0.0306776553926119 0.25502028
NSC 671165 Null 0.0306776553926119 0.2759827
NSC 671865 Null 0.0306776553926119 0.54770011
NSC 677959 16.beta.-N-methylpiperazino-5-androstene-3.beta.,17.beta.-diol 0.0306776553926119 0.27269922
NSC 678362 Null 0.0306776553926119 0.33819167
Total:86  Current:59    [First] [Prev] [Next] [Last]